Anastasia Asimakopoulos
Aachen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
How the liver transcriptome and lipid composition influence the progression of nonalcoholic fatty liver disease to hepatocellular carcinoma in a murine model.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: June 04, 2024
The influence of perilipin 5 deficiency on gut microbiome profiles in murine metabolic dysfunction-associated fatty liver disease (MAFLD) and MAFLD-hepatocellular carcinoma.
Journal: Frontiers in cellular and infection microbiology
Published: June 04, 2024
Perilipin 5 deletion protects against nonalcoholic fatty liver disease and hepatocellular carcinoma by modulating lipid metabolism and inflammatory responses.
Journal: Cell death discovery
Published: October 31, 2023
The Interplay of TGF-β1 and Cholesterol Orchestrating Hepatocyte Cell Fate, EMT, and Signals for HSC Activation.
Journal: Cellular and molecular gastroenterology and hepatology
Published: August 22, 2023
Cholesterol modulates type I/II TGF-β receptor complexes and alters the balance between Smad and Akt signaling in hepatocytes.
Journal: Communications biology
Published: March 10, 2023
Lipid-Independent Regulation of PLIN5 via IL-6 through the JAK/STAT3 Axis in Hep3B Cells.
Journal: International journal of molecular sciences
Published: February 15, 2023
Understanding the Role of Perilipin 5 in Non-Alcoholic Fatty Liver Disease and Its Role in Hepatocellular Carcinoma: A Review of Novel Insights.
Journal: International journal of molecular sciences
Published: March 24, 2021
A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma.
Journal: International journal of molecular sciences
Published: February 23, 2021
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.
Journal: Nature communications
Published: February 17, 2016
Polymorphisms in STAT4 are not associated with treatment response and spontaneous clearance of hepatitis C virus in europeans.
Journal: Hepatology (Baltimore, Md.)
Published: January 28, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026